Anti-inflammatory tripeptide from alpha-melanocyte-stimulating hormone targeting NF-κB and gut inflammation
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Oral
Route
1 recommended
Sites
Once daily
Frequency
Preparation
KPV (Alpha-MSH Fragment) in its prescribed form
Clean, dry storage container
Measuring device if applicable (oral syringe, measuring cup)
Calendar or reminder app for dosing schedule
Pro tip
Prepare all supplies on a clean surface before you begin. Having everything ready makes the process smoother and more sterile.
Mixing
Example calculation
KPV (Alpha-MSH Fragment) comes in pre-measured doses or forms. Follow the exact dosing instructions on your prescription label. No reconstitution or mixing is typically required for this formulation.
Dose calculation
Use KPV (Alpha-MSH Fragment) exactly as prescribed. Each unit contains the labeled amount. Your healthcare provider will determine the appropriate dose based on your individual needs and response.
Location
Site 01
Not applicable—this is not an injectable formulation
Follow your provider's instructions for this injection site. Rotate sites regularly to prevent tissue damage.
Rotate between 1 sites to prevent tissue buildup and ensure consistent absorption.
Pro tip
Rotate your injection sites with each dose to prevent lipohypertrophy (buildup of fatty tissue). Keep a simple log of where you last injected.
Step by step
Follow the specific administration instructions for your KPV (Alpha-MSH Fragment) formulation
Take or apply as directed by your healthcare provider
Store properly between uses according to package instructions
Pro tip
This peptide uses kpv (alpha-msh fragment) is administered oral—no injection required. Inject at a 90 degree angle into the muscle. Aspirate before injecting to ensure you haven't hit a blood vessel.
Timing
Optimal timing
Best time
Take KPV (Alpha-MSH Fragment) at the same time each day for consistent blood levels. Morning dosing with breakfast is often preferred, but follow your healthcare provider's specific instructions.
With food?
KPV (Alpha-MSH Fragment) can typically be taken with or without food. Taking it with a light meal may help reduce any GI discomfort. Avoid taking with grapefruit juice or high-fat meals unless specifically directed.
Stacking notes
KPV (Alpha-MSH Fragment) should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
Sample daily schedule
As prescribed (once daily)
As prescribed by your healthcare provider injection
Site: Oral—rotate sites if applicable
Maintain a consistent schedule for optimal results with KPV (Alpha-MSH Fragment). Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.
Dosing tiers
Dose
200 mcg
Frequency
Once daily
Duration
4-6 weeks
Lower end of the subcutaneous practice range for systemic anti-inflammatory use; KPV is the C-terminal tripeptide of alpha-MSH and acts on NF-kB signaling [3][6].
Dose
300-500 mcg
Frequency
Once daily
Duration
4-6 weeks
Most commonly used subcutaneous practice dose for systemic/extra-intestinal inflammation; some practitioners escalate toward 500 mcg during acute flares [6].
Dose
1000-1500 mcg
Frequency
Once daily
Duration
4-6 weeks
Oral route is used for gut-directed effects (e.g., IBD/ulcerative colitis models), taking advantage of PepT1 uptake; preclinical colitis studies support this application, doses are research practice [2][6].
Dose
0.01-0.1% cream or serum
Frequency
Twice daily
Duration
7-14 days (acute) up to 4-8 weeks (chronic)
Applied as a 0.01-0.1% topical formulation to affected skin for localized inflammation (eczema, rosacea, post-procedure redness); penetration enhancers are often added. Research/practice use [6].
Preservation
Before mixing
Store KPV (Alpha-MSH Fragment) in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
After mixing
Once reconstituted, KPV (Alpha-MSH Fragment) should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Shelf life after mixing
Use within the timeframe specified on product labeling (typically 14-28 days refrigerated)
Signs of degradation
Discard the vial immediately if you notice any of these:
Solution appears cloudy, discolored, or contains visible particles (should be clear)
Product has been exposed to temperatures outside the recommended storage range
Product has been frozen (unless specifically designed for freeze-thaw stability)
Expiration date has passed or reconstituted solution has exceeded its use-by date
Unusual odor, color change, or visible contamination
Important
When to stop
Severe or worsening side effects that don't improve with dose adjustment or supportive care
Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
Your healthcare provider recommends discontinuation based on your clinical response
Development of any new medical condition that may be contraindicated with KPV (Alpha-MSH Fragment)
Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
Abnormal lab results or clinical markers that suggest adverse effects
KPV (Alpha-MSH Fragment) should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
Clean technique checklist
Wash hands thoroughly with soap and water before handling supplies
Swab vial tops and injection site with alcohol and let dry
Never touch the needle tip or allow it to contact non-sterile surfaces
Use a new syringe and needle for each injection
Dispose of used sharps in a proper sharps container
Store reconstituted peptides according to the storage instructions above
Published research
Sun J, et al. · 2021
A novel hydrogel delivery system stabilized KPV for ulcerative colitis treatment, showing 50% reduction in colonic myeloperoxidase activity in rat models. Intestinal epithelial barrier function was preserved, preventing disease progression.
Xiao B, et al. · 2017
Hyaluronic acid-nanoparticles delivered KPV directly to inflamed intestinal epithelium, achieving stronger anti-inflammatory effects than standard delivery. TNF-α was significantly downregulated, demonstrating targeted efficacy.
Brzoska T, et al. · 2008
This comprehensive review established KPV as a potent anti-inflammatory tripeptide derived from alpha-MSH that lacks the pigmentary effects of the parent hormone. KPV shows promise for treating inflammatory bowel disease, fibrosis, and arthritis.
Kannengiesser K, et al. · 2008
Original preclinical research demonstrated KPV efficacy in multiple murine inflammatory bowel disease models with approximately 50% reduction in colonic myeloperoxidase activity. The mechanism involved NF-κB pathway inhibition.
Brzoska T, et al. · 2010
Analysis revealed KPV's anti-inflammatory effects work through NF-κB and MAP kinase pathway inhibition—the same mechanism as full-length alpha-MSH but without unwanted side effects. KPV represents a minimal anti-inflammatory fragment.
PeptidesExplorer (practitioner protocol compilation) · 2026
Documents commonly used research/practice KPV doses: 200-500 mcg subcutaneous daily, 1000-1500 mcg oral daily for gut inflammation, and 0.01-0.1% topical formulations twice daily; notes no completed human trial has established an official dose.
Head to head